Literature DB >> 14980084

Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.

Yasumichi Inoue1, Masatoshi Kitagawa, Kikuo Onozaki, Hidetoshi Hayashi.   

Abstract

Smad proteins are crucial for the intracellular signaling of transforming growth factor-beta (TGF-beta). After receptor-induced activation, Smad proteins are phosphorylated and translocated to the nucleus to activate transcription of a select set of target genes. Here, we investigated the turnover of Smad3, positively regulating Smad for TGF-beta signaling. In a steady state, the inhibition of proteasome activity leads to stabilization of Smad3 protein. Smad proteins are multi-ubiquitinated and degraded independently of the phosphorylation induced by the TGF-beta receptors. Moreover, the degradation of Smad3 was enhanced by treatment with TGF-beta, and phosphorylated Smad3 was accumulated on proteasome inhibition. Ubiquitination of phosphorylated Smad3 but not Smad3(3SA), a receptor-mediated phosphorylation-incompetent mutant, was observed in the nucleus after treatment with TGF-beta. These findings suggest that, in a steady state, Smad3 is constitutively degraded via the ubiquitin-proteasome pathway in the cytoplasm and that, in response to TGF-beta, it is phosphorylated and translocated into the nucleus, where it is degraded through the ubiquitin-proteasome pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14980084     DOI: 10.1089/107999004772719909

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  2 in total

1.  Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.

Authors:  Xing Guo; Alejandro Ramirez; David S Waddell; Zhizhong Li; Xuedong Liu; Xiao-Fan Wang
Journal:  Genes Dev       Date:  2008-01-01       Impact factor: 11.361

2.  hCLP46 increases Smad3 protein stability via inhibiting its ubiquitin-proteasomal degradation.

Authors:  Yingying Xing; Qiaoyun Chu; Run Feng; Wei Wang; Lixin Liu; Zhongbing Lu
Journal:  Protein Cell       Date:  2015-10       Impact factor: 14.870

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.